Stealth BioTherapeutics Inc.

Alnylam Pharmaceuticals is a pioneering biopharmaceutical company based in Cambridge, MA, focused on developing RNA interference (RNAi) therapeutics to transform the treatment landscape for diseases by silencing the genes responsible for their progression. Leveraging the body's natural processes, Alnylam aims to deliver targeted medicines that address both rare and prevalent diseases, prioritizing patient needs and their experiences. Driven by a profound commitment to scientific innovation, Alnylam's robust pipeline encompasses various therapeutic areas and reflects its dedication to improving lives through impactful medicines. The company also embraces corporate responsibility, seeking to extend its positive influence beyond medication development by being a supportive force for the communities it serves. Generated from the website

Proteostasis Therapeutics is a biopharmaceutical company based in Cambridge, MA that focuses on developing novel therapeutics for diseases caused by dysfunctional protein regulation. With a dedicated team of researchers and scientists, the company is committed to advancing drug discovery and development in the field of proteostasis to address unmet medical needs. Generated from their business information

From the website:Looking for the best way to get in touch with us If you have any questions or comments, please connect with us the way that you prefer most.